You just read:

PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries

News provided by

PharmaMar, SA

18 May, 2017, 14:00 BST